Interstitial lung disease in lung cancer. Separating disease progression from treatment effectsDANSON, Sarah; BLACKHALL, Fiona; HULSE, Paul et al.Drug safety. 2005, Vol 28, Num 2, pp 103-113, issn 0114-5916, 11 p.Article

The impact on the multidisciplinary team of molecular profiling for personalized therapy in non-small cell lung cancerBLACKHALL, Fiona; THATCHER, Nick; BOOTON, Richard et al.Lung cancer. 2013, Vol 79, Num 2, pp 101-103, issn 0169-5002, 3 p.Article

Treatment and detection of ALK-rearranged NSCLCPETERS, Solange; TARON, Miquel; BUBENDORF, Lukas et al.Lung cancer. 2013, Vol 81, Num 2, pp 145-154, issn 0169-5002, 10 p.Article

How can we optimise concurrent chemoradiotherapy for inoperable stage III non-small cell lung cancer?BAYMAN, Neil; BLACKHALL, Fiona; McCLOSKEY, Paula et al.Lung cancer. 2014, Vol 83, Num 2, pp 117-125, issn 0169-5002, 9 p.Article

Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cellsSTOVOLD, Rachel; BLACKHALL, Fiona; MEREDITH, Suzanne et al.Lung cancer. 2012, Vol 76, Num 3, pp 263-268, issn 0169-5002, 6 p.Article

Update on targeted therapies for small cell carcinoma of the lungGRIFFITHS, Richard W; LORIGAN, Paul; THATCHER, Nicholas et al.Targeted oncology. 2008, Vol 3, Num 3, pp 205-215, issn 1776-2596, 11 p.Article

Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancerBLACKHALL, Fiona H; SHEPHERD, Frances A.Hematology/oncology clinics of North America. 2004, Vol 18, Num 5, issn 0889-8588, ix, 1121-1141 [21 p.]Article

The Manchester Cough in Lung Cancer Scale: The Development and Preliminary Validation of a New Assessment ToolMOLASSIOTIS, Alex; ELLIS, Jackie; WAGLAND, Richard et al.Journal of pain and symptom management. 2013, Vol 45, Num 2, pp 179-190, issn 0885-3924, 12 p.Article

Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trialSHEIKH, Hamid; COLACO, Rovel; LORIGAN, Paul et al.Lung cancer. 2011, Vol 74, Num 1, pp 75-79, issn 0169-5002, 5 p.Article

Circulating Tumor Cells as a Window on Metastasis Biology in Lung CancerHOU, Jian-Mei; KREBS, Matthew; WARD, Tim et al.The American journal of pathology. 2011, Vol 178, Num 3, pp 989-996, issn 0002-9440, 8 p.Article

Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non-Small-Cell Lung CancerSORIA, Jean-Charles; MARK, Zsuzsanna; HEI, Yong-Jiang et al.Journal of clinical oncology. 2011, Vol 29, Num 33, pp 4442-4451, issn 0732-183X, 10 p.Article

Modeling of lung cancer by an orthotopically growing H460SM variant cell line reveals novel candidate genes for systemic metastasisJIANG LIU; BLACKHALL, Fiona; TSAO, Ming-Sound et al.Oncogene (Basingstoke). 2004, Vol 23, Num 37, pp 6316-6324, issn 0950-9232, 9 p.Article

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung CancerSOLOMON, Benjamin J; MOK, Tony; IYER, Shrividya et al.The New England journal of medicine. 2014, Vol 371, Num 23, pp 2167-2177, issn 0028-4793, 11 p.Article

Extrapulmonary small cell carcinoma: a clinicopathological study with identification of potential diagnostic mimicsOUINN, Anne Marie; BLACKHALL, Fiona; WILSON, Godfrey et al.Histopathology. 2012, Vol 61, Num 3, pp 454-464, issn 0309-0167, 11 p.Article

Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer - Evidence from a phase II trialCOLACO, Rovel; SHEIKH, Hamid; LORIGAN, Paul et al.Lung cancer. 2012, Vol 76, Num 1, pp 72-77, issn 0169-5002, 6 p.Article

Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer groupCALIFANO, Raffaele; GRIFFITHS, Richard; THATCHER, Nick et al.Lung cancer. 2011, Vol 73, Num 3, pp 338-344, issn 0169-5002, 7 p.Article

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung CancerSHAW, Alice T; KIM, Dong-Wan; WU, Yi-Long et al.The New England journal of medicine. 2013, Vol 368, Num 25, pp 2385-2394, issn 0028-4793, 10 p.Article

Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan―Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non―Small-Cell Lung CancerRAMALINGAM, Suresh S; BLACKHALL, Fiona; LETRENT, Stephen P et al.Journal of clinical oncology. 2012, Vol 30, Num 27, pp 3337-3344, issn 0732-183X, 8 p.Article

Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non-Small-Cell Lung CancerSORIA, Jean-Charles; SMIT, Egbert; KHAYAT, David et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1527-1533, issn 0732-183X, 7 p.Article

Platinum-based chemotherapy with thoracic radiotherapy in stage III good performance status non-small cell lung cancer patientsBAKA, Sofia; FAIVRE-FINN, Corinne; PAPAKOTOULAS, Pavlos et al.European journal of cancer. Supplement (1990). 2005, Vol 3, Num 3, pp 41-50, issn 1359-6349, 10 p.Conference Paper

Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung CancerPOLANSKI, Radostaw; HODGKINSON, Cassandra L; SMITH, Paul D et al.Clinical cancer research (Print). 2014, Vol 20, Num 4, pp 926-937, issn 1078-0432, 12 p.Article

Modafinil for the Treatment of Fatigue in Lung Cancer: Results of a Placebo-Controlled, Double-Blind, Randomized TrialSPATHIS, Anna; FIFE, Kate; BEE WEE et al.Journal of clinical oncology. 2014, Vol 32, Num 18, pp 1882-1888, issn 0732-183X, 7 p.Article

Applying Best―Worst scaling methodology to establish delivery preferences of a symptom supportive care intervention in patients with lung cancerMOLASSIOTIS, Alex; EMSLEY, Richard; SMITH, Jaclyn et al.Lung cancer. 2012, Vol 77, Num 1, pp 199-204, issn 0169-5002, 6 p.Article

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non―Small-Cell Lung Cancer: MONET 1SCAGLIOTTI, Giorgio V; VYNNYCHENKO, Ihor; DEDIU, Mircea et al.Journal of clinical oncology. 2012, Vol 30, Num 23, pp 2829-2836, issn 0732-183X, 8 p.Article

Considerations in Developing and Delivering a Nonpharmacological Intervention for Symptom Management in Lung Cancer: The Views of Patients and Informal CaregiversELLIS, Jackie; WAGLAND, Richard; BLACKHALL, Fiona et al.Journal of pain and symptom management. 2012, Vol 44, Num 6, pp 831-842, issn 0885-3924, 12 p.Article